Literature DB >> 22768021

An update on brain imaging in parkinsonian dementia.

Myria Petrou1, Vikas Kotagal, Nicolaas I Bohnen.   

Abstract

Disturbances of cognition are frequent in Parkinson's disease (PD). Unlike severe loss of dopamine early in PD, extensive cholinergic losses have been consistently reported in PD with dementia. Cholinergic imaging suggests that basal forebrain cholinergic system degeneration appears early in PD and worsens with dementia development. Cortical cholinergic denervation is similar in PD with dementia and dementia with Lewy bodies, supporting a common disease spectrum, at least with respect to cholinergic pathology. Presence of cerebral amyloidopathy in the setting of parkinsonism may accelerate cognitive decline. Novel MRI techniques illustrate the widespread presence of neurodegeneration in PD with dementia, affecting white matter tracts and connectivity functions. This review will outline current concepts regarding dementia development in PD and discuss their correlation with functional and structural neuroimaging including PET and MRI.

Entities:  

Year:  2012        PMID: 22768021      PMCID: PMC3387991          DOI: 10.2217/iim.12.10

Source DB:  PubMed          Journal:  Imaging Med        ISSN: 1755-5191


  121 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.

Authors:  R Hilker; A V Thomas; J C Klein; S Weisenbach; E Kalbe; L Burghaus; A H Jacobs; K Herholz; W D Heiss
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

3.  Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.

Authors:  Enikö Kövari; Gabriel Gold; François R Herrmann; Alessandra Canuto; Patrick R Hof; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Acta Neuropathol       Date:  2003-04-10       Impact factor: 17.088

4.  Posterior hypoperfusion in Parkinson's disease with and without dementia measured with arterial spin labeling MRI.

Authors:  Koji Kamagata; Yumiko Motoi; Masaaki Hori; Michimasa Suzuki; Atsushi Nakanishi; Keigo Shimoji; Shinsuke Kyougoku; Ryohei Kuwatsuru; Keisuke Sasai; Osamu Abe; Yoshikuni Mizuno; Shigeki Aoki; Nobutaka Hattori
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

5.  An estimate of the prevalence of dementia in idiopathic Parkinson's disease.

Authors:  R Mayeux; Y Stern; R Rosenstein; K Marder; A Hauser; L Cote; S Fahn
Journal:  Arch Neurol       Date:  1988-03

6.  Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.

Authors:  M T Hu; S J White; K R Chaudhuri; R G Morris; G M Bydder; D J Brooks
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

7.  Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

Authors:  P M Mattila; J O Rinne; H Helenius; D W Dickson; M Röyttä
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

8.  Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?

Authors:  Sun-Ah Choi; Virgilio Gerald Hilario Evidente; John N Caviness; Holly A Shill; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; Charles H Adler; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2009-12-03       Impact factor: 17.088

9.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

10.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

Authors:  M P Laakso; K Partanen; P Riekkinen; M Lehtovirta; E L Helkala; M Hallikainen; T Hanninen; P Vainio; H Soininen
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  6 in total

1.  The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.

Authors:  Dilek Betul Arslan; Hakan Gurvit; Ozan Genc; Ani Kicik; Kardelen Eryurek; Sevim Cengiz; Emel Erdogdu; Zerrin Yildirim; Zeynep Tufekcioglu; Aziz Müfit Uluğ; Basar Bilgic; Hasmet Hanagasi; Erdem Tuzun; Tamer Demiralp; Esin Ozturk-Isik
Journal:  J Neural Transm (Vienna)       Date:  2020-07-06       Impact factor: 3.575

2.  Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.

Authors:  Yaqian Xu; Jing Yang; Xinyu Hu; Huifang Shang
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

Review 3.  Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia.

Authors:  Stephen N Gomperts
Journal:  Continuum (Minneap Minn)       Date:  2016-04

Review 4.  Cholinergic dysfunction in Parkinson's disease.

Authors:  Martijn L T M Müller; Nicolaas I Bohnen
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

Review 5.  Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Authors:  Jennifer G Goldman; Beth A Vernaleo; Richard Camicioli; Nabila Dahodwala; Roseanne D Dobkin; Terry Ellis; James E Galvin; Connie Marras; Jerri Edwards; Julie Fields; Robyn Golden; Jason Karlawish; Bonnie Levin; Lisa Shulman; Glenn Smith; Christine Tangney; Cathi A Thomas; Alexander I Tröster; Ergun Y Uc; Noreen Coyan; Crystal Ellman; Mike Ellman; Charlie Hoffman; Susan Hoffman; Don Simmonds
Journal:  NPJ Parkinsons Dis       Date:  2018-06-26

6.  A quick test of cognitive speed can predict development of dementia in Parkinson's disease.

Authors:  Mattis Jalakas; Sebastian Palmqvist; Sara Hall; Daniel Svärd; Olof Lindberg; Joana B Pereira; Danielle van Westen; Oskar Hansson
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.